Annaida Technologies is a pioneering company specializing in non-invasive technology to investigate the chemistry of microscopic life while maintaining its integrity. Their flagship product, EmbryoSpin, leverages micro-MRS technology to provide a precise understanding of cellular metabolism, aiding research in areas such as toxicology, drug discovery, and reproductive health. This technology improves embryo selection in fertility clinics, enhancing patient outcomes and facilitating research for both academic and corporate laboratories. Annaida is dedicated to driving advancements in cellular analysis and treatment efficacy, primarily focusing on revolutionizing fertility treatments and expanding drug discovery capabilities.